Public Lecture Series
24th October (Friday), 3-5pm
Venue: C333, Arts C Building
Professor in Anthropology at the Institute of Social and Cultural Anthropology of the University of Oxford, and Fellow of Green Templeton College.
Over the last decade, small-scale Chinese medical practices have made inroads into East Africa, spreading out thinly throughout its urban areas and catering to clientele from all walks of society. This lecture highlights how international trade relations andregulations affect their medical practice at the grassroots. On a theoretical level, this lecture critiques the concept of culture as defined by sameness in terms of religion, language, and territory. Rather, cultural life emerges as realms within which difference is recognised and responded to, turning ‘the other’ into an ‘inclusive other’, particularly in the context of reproductive health.
Staff and students are all welcome!
Center for BionetworkingPublic Lecture Series
1st October (Wed), 4pm-6pm
Venue: Lecture Theatre 144, Jubilee Building
University of Lincoln
The UNESCO Bioethics Programme (1993) has navigated moral discourses in science and technology, in particularly in relation to the human body, and has adopted three international declarations, on human genomics and genetics and on bioethics. Based on fieldwork in Kenya, South Africa and at UNESCO headquarters in Paris, Adèle Langlois will ‘lift the lid’ on the drafting process behind these declarations – the power imbalances, the compromises and the breakthroughs. She will also show how the declarations have influenced research ethics at national level.
Adèle Langlois is a senior lecturer at the University of Lincoln.
Her book, Negotiating Bioethics, was published by Routledge in 2013.
The Centre for Bionetworking presents a guest lecture:
‘Regenerative medicine research as global collaborative project:
opportunities, challenges, conflicts’
Tuesday 26th March, 4pm – 5.30 pm
Room 115, Jubilee Building
This lecture focuses on the formation of the first trans-continental clinical trials infrastructure in the field of regenerative medicine, across the contexts of North America and Asia. It contributes to an understanding of the processes and challenges involved in the development of large-scale clinical research collaborations in stem cell medicine, an emerging field of medical research for which currently no internationally harmonized regulatory framework exists. The lecture explores the roles and challenges of scientific self-government and standardization, against a background of regulatory, institutional and cultural heterogeneity. It shows that the creation of standardized inter-institutional zones, in the context of international research projects, is a complex and highly contested process that is based on the intensive restructuration of local research and innovation practices. Unsurprisingly, in the context of Asia, these processes go along with vital forms of resistance and alter-standardization, that gradually result in a pluralization of international clinical research standards and practices itself. Achim Rosemann is a researcher for the ESRC Bionetworking in Asia project, at the University of Sussex. His recent research has focused on the forging of trans-continental knowledge partnerships in translational medicine between researchers in China and the USA.
For inquiries: firstname.lastname@example.org
Bionetworking in Asia Public Lecture Series and the Centre for Global Health Policy present:
‘Regenerative medicine in Europe: Political conflicts, economic biases in regulation’
University of Sussex
Date: Wednesday 27th of February
Location: Arts A 103, University of Sussex
The life sciences and the global bioeconomy are moving ever upward in governments’ agendas, driven by visions of economic reward and a medical revolution. EU regulation moulds the international dynamics of new biomedical markets.
Alex Faulkner traces developments in EU regulation, including tissue engineering, medical devices and cell therapy, and stem cell therapy, analysing debates on the collection of human materials, assessment of products for safety and market authorisation, and patenting of biotechnologies.
Alex shows how the emergence of a ‘harmonised’ product regulation for ‘Advanced Therapy Medicinal Products’ masks conflicts between industry sectors, which exploit ambiguities in the definition of materials and ‘modes of action’. A case at the European Court of Justice further illustrates the politically malleable nature of regenerative cell technologies.
For inquiries: email@example.com
Bionetworking in Asia and Sussex Asian Studies lecture series present:
‘China’s Bio-Governance: Imagined Cosmopolitan Communities’
Joy Zhang – University of Kent
The life sciences and environmental studies largely define the world’s biological future, and China is key in the formation and deliverance of transnational initiatives in both fields. Drawing on studies from stem cell research, synthetic biology and environmental health in China, Joy shows how stakeholders (i.e. clinicians, scientists, civil groups and policy makers) seek alliances within and without China in promoting its interests. Illustrating how China’s experience suggests the need for a new form of imagined communities, Joy argues how solidarity lies not so much in establishing institutional frameworks for stability and consensus, but in identifying solutions to collective problems.
The lecture will be held on the 2nd of October, from 4pm-6pm in Arts A103, Arts C Building.
All are welcome!
Joy Y. Zhang is a Lecturer in Sociology at the University of Kent. She received her medical degree at Peking University and her PhD in sociology at the London School of Economics and Political Science. She is the author of two books: The Cosmopolitanization of Science: Stem Cell Governance in China (2012) and Green Politics in China: Environmental Governance and State-Society Relations (2013)
Sussex Asian Studies Lecture Series/ Bionetworking in Asia presents:
Thursday 19 April, 4pm – 6 pm
‘Clinical translation of stem cell research in Asia: Strides forward and missteps’
Douglas Sipp – Science Policy and Ethics Studies Unit, RIKEN, Center for Developmental Biology, Kobe. Japan
Countries in East and Southeast Asia regard stem cell research and regenerative medicine as central to developing a leading position in biotechnology and biomedicine. But in several notable cases application-oriented research and clinical experimentation are prioritized over a responsible, rigorous, safe, and ethical approach. Douglas Sipp will review historical and socioeconomic factors that led to this situation, and provide a summary of problem areas in the clinical translation of stem cell research, and the steps taken by various Asian countries to remedy this.
Doug Sipp’s work focuses on issues in the clinical application and commercialization of stem cell therapeutics and stem cell research in the Asia-Pacific region. He widely publishes in the field, and serves on numerous committees and editorial boards in the fields of developmental and stem cell biology, and regenerative medicine.
Doug Sipp will be talking on the 19th of April, from 4pm-6pm in Arts A005, Arts C Building. All are welcome.